Dr. Sagner is a medical doctor and researcher specializing in sports medicine and preventive medicine. Dr. Sagner was the medical director and attending physician at Europe’s first University medical center section for preventive medicine and lifestyle medicine where he oversaw an interdisciplinary team of medical doctors, nurses, exercise physiology specialists, physiotherapists and nutritionists and was involved in top league athletes. He then co-founded a private clinic group and research institute for cardiology, metabolism, endocrinology, preventive medicine and sports medicine where he looks after elite athletes, VIPs and executives. As a clinician he has spearheaded interventions in the field of endocrinology and cardiometabolic prevention such as the use of GLP1 agonists in Europe. His focus is on interdisciplinary approaches, looking at the systems of the human body as part of an integrated whole, incorporating biochemical, physiological, and environment interactions and translating these systems biology principles into clinical practice. He works on the convergence of systems biology and consumer-driven healthcare to transform medicine from its current reactive approach to an approach that is predictive, preventive, personalized and participatory (P4). As a public health expert, he has spearheaded several international initiatives in the field of systems biologydriven preventive medicine working with governments and NGOs. One of his interests is closing the gap between clinical practice and public health to promote more effective and patient-oriented care and preventive interventions. For that he has collaborated with many NGOs such as the World Heart Federation (WHF), the World Obesity Federation and the World Health Organization (WHO) where he established the ‘cell to community’ approach in prevention. Dr. Sagner is the director of the European Society of Preventive Medicine, member of the European Union Platform for Action on Diet, Physical Activity and Health and partner of the European Innovation Partnership on Active and Healthy Aging. He is a member for the UK Parliamentary Group for Longevity under Rt Hon Matt Hancock MP.
He has numerous media appearances in print such as GQ Magazine and TV as a sought-after health expert. As a consultant he has supported companies, organizations and governments navigate the complexities of healthcare innovation in Europe, Asia and the United States. He is the current Editor-in-Chief of Progress in Preventive Medicine, a peerreviewed journal for P4 medicine and systems biology-based prevention. He co-authored the leading medical textbook on sports medicine and internal medicine and is the editor of several textbooks on preventive medicine, of which the English edition won the British Medical Book Prize and is used at Harvard Medical School for the Lifestyle Medicine courses. He currently focuses on -omics driven prediction and prevention of diseases with a systems biology approach for which he collaborates with interdisciplinary groups in medicine, biotech, mathematics, physics, forecasting, behavioral economics and complex systems theory. Dr. Sagner is on several advisory boards of international biotechnology companies.